Galectin Therapeutics Announces Completion of Enrollment in First Cohort of ... MarketWatch Over time, patients with fatty liver disease can develop fibrosis, or scarring of the liver, and it is estimated that as many as three million individuals will develop cirrhosis, a severe liver disease where liver transplantation is the only current ... |
